Virupaksha stands at the forefront of pharmaceutical manufacturing, delivering excellence with a commitment to quality and innovation that resonates through every aspect of its operations. Specializing in high-purity Fluconazole, the company aligns its production processes with stringent WHO-GMP standards, ensuring that each batch meets international safety and efficacy benchmarks vital for treating conditions like cryptococcal meningitis.
The dedication to quality is further underscored by their ISO 9001 certification, which guarantees robust management practices focused on continual improvement and customer satisfaction. Additionally, Virupaksha’s adherence to ISO 14001 reflects their unwavering responsibility towards environmental sustainability;
they strive not only for therapeutic advancements but also for eco-friendly solutions that contribute positively to global health outcomes. As a result, healthcare providers can trust in Virupaksha’s products as they navigate the complexities of treatment options available today.
Other Latest News
- Aptar acquires Mod3 Pharma’s trial materials manufacturing capabilities July 17, 2025 4:56 pm Clinical Trials Arena Aptar Pharma has announced the acquisition of Mod3 Pharma’s clinical trial materials manufacturing capabilities from SWK Holdings. Mod3 Pharma was previously known as Enteris Biopharma. This acquisition is a strategic move aimed at strengthening Aptar …
- Nigeria targets $10 billion pharma sector to boost medicine security July 11, 2025 3:18 pm Premium Times As Nigeria seeks to secure its medicine supply and reduce dependence on imports, the pharmaceutical industry is targeting a tenfold expansion, projecting growth from an estimated $2 billion to $10 billion within the next five years. This ambition, driven …
- Nigeria Pharma Industry Targets $10bn, Medicine Security July 10, 2025 5:53 am Leadership The Association of Community Pharmacists of Nigeria (ACPN) has said that the pharmaceutical industry is on the path to transformative growth as local manufacturers and investors channel multi-million-dollar investments into Active Pharmaceutical Ingredient …
- From Laurus Labs, Lupin to Biocon— Pharma stocks rise up to 3% despite Trump's 200% tariff threat July 9, 2025 5:13 am Mint Pharma stocks exhibited remarkable resilience in the morning trade on Wednesday, July 9, despite US President Donald Trump's threat of a very high tariff of up to 200 per cent. Several pharma stocks, including Laurus Labs, Lupin, Biocon, Cipla and Divi …
- Pharma Stocks Slide Up To 3% On US Tariff Concerns; Aurobindo, DRL, Lupin Among Top Losers July 8, 2025 9:14 am News18 Last Updated:July 08, 2025, 12:48 IST Shares of Indian pharma companies fell on July 8 as investor concerns resurfaced following US President Trump’s announcement of new tariff Indian pharma stocksPharma Stocks Fall: Shares of Indian pharma companies fell …
- European Commission fines Alchem for role in pharma cartel July 7, 2025 6:59 pm ICLG Penalty concludes lengthy investigation into price-fixing and other cartelist behaviour involving seven p... Penalty concludes lengthy investigation into price-fixing and other cartelist behaviour involving seven pharmaceutical manufacturers. The European …
- How US Tariffs Could Disrupt The Generic Drugs Supply Chain July 1, 2025 8:55 am MENAFN (MENAFN- Swissinfo) Generic drugs run on thin margins and tight supply chains. Any disruption triggered by increased tariffs could raise prices, push some manufacturers out of the market and even worsen medicine shortages. This content was published on …
- UP’s Much-Awaited Pharma Park All Set To Become A Reality By 2027 June 30, 2025 6:43 pm News18 Last Updated:June 30, 2025, 15:49 IST With construction underway on over 350 acres in the first phase, the project is expected to catalyse investments worth over Rs 12,000 crore With construction in full swing, the park is expected to show physical results …
- US trade tariffs and the potential impact on pharma supply chains June 30, 2025 6:24 pm Pharmaceutical Technology When Donald Trump was elected the 47th president of the United States of America, the outlook for pharmaceuticals was unclear, with 55% of North American industry professionals expecting negative repercussions when surveyed by GlobalData later that month. …
- Stock market: Valuation froth? 38% BSE200 stock trading above 5-year average multiples June 30, 2025 7:27 am Business Today The 10 per cent Nifty rally from the April bottom has plucked out valuation comfort from the market, Emkay Global said on Monday, saying 38 per cent of the BSE200 stocks are now trading above the 5-year long-tern average (LTA) valuations against 12 per …
- CPHI & PMEC China 2025: Asia’s pharma powerhouse strengthens global linkages June 26, 2025 4:24 am Biospectrum Asia CPHI & PMEC China 2025: Asia’s pharma powerhouse strengthens global linkages June 26, 2025 | Thursday | News | By Special Coverage by| Saradha Mani , BioSpectrum Asia Asia’s largest pharmaceutical exhibition hosted over 90,000 participants, 3,500+ …
- EVA Pharma and CHICO Pharmaceutical unite to localise oncology API production for the Middle East and Africa June 24, 2025 12:09 pm Biospectrum Asia EVA Pharma and CHICO Pharmaceutical unite to localise oncology API production for the Middle East and Africa June 24, 2025 | Tuesday | News | By Ankit Kankar | ankit.kankar@mmactiv.com Strategic MoU signed at CPHI China 2025 aims to strengthen regional …
- Top stocks to watch: Bajaj Finance, SpiceJet, Adani Ports, NTPC, Vedanta, Sun Pharma, ITC June 16, 2025 4:12 am Business Today Indian benchmark indices settled with bit cuts on Friday amid weak global cues over geopolitical tensions in the Middle East and consistent foreign outflows. BSE Sensex plunged 573.38 points, or 0.70 per cent, to end at 81,118.60, while NSE's Nifty50 …
- Alembic Pharma shares dip over 2% after USFDA issues 4 observations for Panelav facility June 2, 2025 6:26 am Business Upturn Shares of Alembic Pharmaceuticals fell over 2% on Monday following news that the United States Food and Drug Administration (USFDA) issued four observations after inspecting the company’s API-I & II facility at Panelav, Gujarat. As of 10:22 AM, the …
- Top stocks to watch: Vodafone Idea, Niva Bupa Health, Ircon, Nykaa, Titagarh, Alembic Pharma June 2, 2025 4:47 am Business Today Indian benchmark indices settled lower on Friday amid mixed global cues amid resurfacing of the US tariffs and rising geopolitical concerns. BSE Sensex fell 182.01 points, or 0.22 per cent, to settle at 81,451.01, while NSE's Nifty50 dropped 82.90 …
- Stocks in news: Apollo Hospitals, IndiGo, Tata Motors, BPCL, Vodafone Idea June 2, 2025 1:37 am The Economic Times Markets began the June expiry on a muted note and ended marginally lower, continuing the ongoing consolidation phase. In today's trade, shares of Apollo Hospitals, IndiGo, Tata Motors, BPCL, Vodafone Idea among others will be in focus due to various …
- pharma& Secures MHRA Approval for Pegasys API Production at Loba Biotech May 28, 2025 9:55 pm Pharmaceutical Technology pharmaand GmbH (pharma&) has received a regulatory variation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), authorizing its wholly owned subsidiary, Loba biotech GmbH, as an approved manufacturing site for the API in Pegasys …
- Business News | Akums Reports Q4 FY25 with 12.4% Revenue Growth, FY25 Adj. EBITDA Remained Strong at 12.3% May 27, 2025 10:43 am Latestly NewsVoir New Delhi [India], May 27: Akums Drugs and Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for the quarter and fiscal year ending March 31, 2025 …
- Glenmark Pharma: Nomura retains 'Neutral' stance, sets targets at Rs 1,500 May 26, 2025 4:22 am Business Today Nomura India has released a report maintaining a 'Neutral' rating on Glenmark Pharmaceuticals Ltd, setting a target price of Rs 1,500 by September 2025. The valuation is grounded on a sum-of-the-parts analysis, with the base business excluding …
- India’s Warren Buffetts are betting big on these high-profit pharma sector stars May 24, 2025 12:50 am Financial Express The investor circles are always abuzz with news and rumours about the picks and sell offs of the super investors, or as well call them, the Warren Buffetts of India. Even one small move by one of these names could cause ripple across the market. Now, …
- Next‑Gen Pharma: AI, ML & Digital Twins Converge at AUTOMA+ 2025 May 20, 2025 2:22 pm Pharmaceutical Technology Big data, Artificial Intelligence (AI), Machine Learning (ML) and other emerging technologies are transforming the pharmaceutical industry right before our eyes – and the clock is ticking for companies that haven’t yet adapted. Integrating these tools into …
- Small Molecule Pharma Companies Are Employing These Advanced Technologies To Get Ahead May 19, 2025 5:35 pm Pharmaceutical Online By Joseph Pategou Small molecule therapeutics account for over 50 percent of global pharmaceutical sales and nearly 70 percent of new FDA approvals in recent years, underscoring their continued dominance in medicine delivery.1 Every day, millions rely on …
- Top stocks to watch: Dr Reddy's, BEL, Divis Labs, Bajaj Auto, Sun Pharma, JSW Steel & Premier Energies May 19, 2025 3:16 am Business Today Indian benchmark indices settled lower on Friday amid profit booking despite positive economic data, rate cut hopes and trade deal expectations with the US. BSE Sensex shed 200.15 points, or 0.24 per cent to settle at 82,330.59, while NSE's Nifty50 …
- Stocks to watch on news today: Dr Reddy’s, Sun Pharma, BEL, JSW Steel, NBCC, Max Healthcare, PNC Infra in focus May 19, 2025 2:21 am Business Upturn Several companies are likely to remain in focus today owing to key regulatory updates, project wins, acquisitions, and strategic corporate announcements. Dr Reddy’s Laboratories received two observations in Form 483 from the USFDA following a GMP …
- How to manage the complexities of synthetic API production in 30 steps May 14, 2025 5:39 pm Pharmaceutical Technology A synthetic active pharmaceutical ingredient (API) can offer a crucial option for drug manufacturing. Yet there can be many complexities in the development of a synthetic API, especially when scaling up from lab to industrial scale. When a pharma …
- Niner Pharma Announces Entry into US Market with 99% Purity Peptides May 13, 2025 1:53 pm The Kingston Whig-Standard Breadcrumb Trail Links Newsfile Article content Dubai, United Arab Emirates–(Newsfile Corp. – May 13, 2025) – Niner Pharma, a leading global API and pharmaceutical manufacturer, today announced plans to enter the US market with its 99% purity peptides. The …
- Onshoring Pharma Ops: Reading Recent EO and Policy Tea Leaves May 10, 2025 12:43 am National Law Review This week, underscoring a commitment to national security, the White House and the Food and Drug Administration (FDA) issued separate communications that aim to bolster domestic drug manufacturing while tightening oversight of foreign facilities. But they …
- Business News | Remlife Global Partners With JiyaYu Lifesciences To Replace Animal Inputs In APIs Via Green Chemistry May 9, 2025 7:26 am Latestly PNN New Delhi [India], May 9: Remlife Global PTE LTD., a Singapore-based subsidiary of BSE-listed Remedium Lifecare Ltd. (India), is pleased to announce a forward-looking partnership with JiyaYu Lifesciences PTE Ltd., a green chemistry technology platform …
- 'We should not have tariffs' on pharma: Pfizer CEO April 29, 2025 5:35 pm Yahoo Finance Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to finalize its decision on whether to place a 25% tariff on pharmaceutical imports. To be sure, he said Tuesday, the government's national security concerns are …
- India Seeks List Of Medicines, Pharma Products Exported To Pakistan On 'Urgent' Basis April 28, 2025 10:46 pm News18 Last Updated:April 28, 2025, 23:01 IST In wake of the Pahalgam terror attack, the department of pharmaceuticals has sought pharmaceutical export data from Pharmexcil, an arm under the ministry of commerce and industry Officials said the majority of Indian …